Vistagen Therapeutics, Inc. - COMM (VTGN)

Historical Portfolio Holders from Q2 2016 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COMM
Shares, excl. options Q1 2024
2.68 M
Holdings value Q1 2024
$14.1 M
Value change Q1 2024
$0
Grand Portfolio weight change Q1 2024
0%
Number of holders
1
Number of buys Q1 2024
0
Number of sells Q1 2024
0
Average buys Q1 2024 %
0
Average sells Q1 2024 %
0
CUSIP
92840H202
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 2.68 M $14.1 M $0 $5.28 1
2023 Q4 2.68 M $13.8 M +$13.8 M $5.14 1
2023 Q2 4.9 K $9.16 K -$4.92 M $1.87 1
2023 Q1 38.3 M $4.77 M -$224 K $0.12 77
2022 Q4 40.1 M $4.13 M -$2.11 M $0.10 73
2022 Q3 55.4 M $8.43 M -$75.5 M $0.15 75
2022 Q2 137 M $120 M +$398 K $0.88 102
2022 Q1 135 M $168 M -$4.39 M $1.24 110
2021 Q4 138 M $268 M +$10.5 M $1.95 100
2021 Q3 131 M $359 M +$21.8 M $2.74 98
2021 Q2 123 M $389 M +$50.8 M $3.15 97
2021 Q1 106 M $225 M +$83 M $2.13 69
2020 Q4 67.2 M $130 M +$118 M $1.94 47
2020 Q3 3.39 M $2.36 M +$679 K $0.70 25
2020 Q2 2.4 M $1.26 M +$97.4 K $0.52 21
2020 Q1 2.02 M $887 K -$187 K $0.44 16
2019 Q4 2.49 M $1.72 M -$886 K $0.69 23
2019 Q3 3.78 M $4.04 M +$1.01 M $1.07 21
2019 Q2 3.2 M $2.32 M -$3.25 M $0.73 20
2019 Q1 6.23 M $7.97 M +$3.93 M $1.28 24
2018 Q4 3.12 M $4.68 M +$718 K $1.50 20
2018 Q3 2.62 M $3.8 M +$311 K $1.45 16
2018 Q2 2.28 M $3.12 M +$390 K $1.37 18
2018 Q1 2.17 M $2.02 M -$2.55 M $0.93 18
2017 Q4 4.71 M $5.23 M +$3.27 M $1.11 13
2017 Q3 1.74 M $2.79 M +$806 K $1.60 12
2017 Q2 1.23 M $2.3 M -$256 K $1.86 13
2017 Q1 1.37 M $2.68 M -$1.24 M $1.96 10
2016 Q4 1.68 M $6.27 M -$374 K $3.73 12
2016 Q3 1.78 M $7.45 M +$19 K $4.17 12
2016 Q2 1.78 M $6.94 M +$6.94 M $3.90 10